12 results
Thumbnail

- D3.27 - Chlorhexidine as a Hidden Everyday Allergen

Thumbnail

D3.20 - Searching for an Alternative Contrast Agent in a Patient Allergic to Multiple Nonionic Iodinated Contrast Media

Thumbnail

D3.22 - Fixed Drug Eruption in a Patient with Vitiligo: localized patch testing as a diagnostic tool

Thumbnail

D3.26 - Anaphylaxis associated with biosimilar Tocilizumab: in vitro and in vivo diagnosis

Thumbnail

D3.30 - Fixed drug eruption: exploring diagnostic considerations and triggers in a cohort study

Thumbnail

D3.265 - Biphasic anaphylaxis secondary to polyethylene glycol in a pediatric patient: a case report

Thumbnail

D3.269 - Drug-Induced Anaphylaxis in Children: A Comparative Analysis of Inpatient vs. Outpatient Settings

Thumbnail

D3.272 - Safety and Efficacy of Vancomycin and Other Antimicrobial Drug Desensitization in Pediatric Patients

Thumbnail

D3.273 - Assessing Anaphylaxis in COVID-19 vaccines: Application of amended Brighton Collaboration Criteria

Thumbnail

D3.274 - Succesful Omalizumab Desensitization in Two Children with Severe Allergic Asthma and Cronic Spontaneous Urticaria

Thumbnail

D3.275 - Anaphylaxis caused by polyhexanide

Thumbnail

D3.276 - Acalabrutinib as premedication in platinum agents desensitization protocols: a case series supporting its role in enhancing tolerance with a repeatible efficacity